Trimeris Inc. (TRMS) Stock Quote

Stock Web

Detailed Quote for Trimeris Inc. (TRMS)

close 52 Week Information

52 Week High

October 02,2009

Close: 3.68

52 Week Low

June 10,2010

Close: 2.03

Today

5d

1m

3m

1y

more

Last Price
2.32

Change $
0.01

Change %
0.43%

Tick

Bid
2.31

Bid Size
400

Ask
2.33

Ask Size
800

Open
2.32

High
2.32

Low
2.31

Prev Close
2.31

Last Trade
10:28

Volume
848

52 Wk Hi
3.68

52 Wk Low
2.03

Market Cap
51.85 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
22,349,841

EPS (TTM)
0.49

PE Ratio
4.70

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Trimeris Inc. (TRMS)

Sector News | Topic News

News for TRMS

Thu, Aug 12, 2010

5:00 PM

Trimeris Reports Financial Results for the Second Quarter 2010 - Business Wire

Wed, Jul 27, 2005

3:21 PM

Notice to All Deutsche Bank Securities Inc. Customers Between 2000 and 2002: The Securities Arbitration Law Firm of Klayman & Toskes, P.A. Urges You to Explore Your Legal Options Regarding the Global Research Analyst Settlement Fund -- DB, GYI, ORCL, TKTX, TRMS - Globe Newswire

More News for TRMS >>

Tags for Trimeris Inc.

Research stocks or mutual funds related to Trimeris Inc. by keywords or tags. Find companies that have a similar focus to TRMS. The keywords below have been associated to TRMS by either user submission or electronic means.

protease inhibitors biotech research pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market Commercial Physical And Biological Research (8731) generic pharmaceutical pharmaceutical investment pharmaceutical patents pharmaceutical research and development trimeris pharmaceutical manufacturing company Biological Products pharmaceutical industry marketing pharmaceutical software pharma manufacturing tenofovir pharmaceutical supply chain novartis pharmaceuticals kv pharmaceutical company pharmaceutical cro viral diseases biopharmaceutical companies pharmaceutical sales pharma pharmaceutical distributors pharma in licensing pharmaceutical development pharmaceutical sales rep pharmaceutical reports biopharmaceutical company pharmaceutical production pharmaceutical consultant biotech pharmaceutical patent Drugs pharmaceutical auctions pharmaceutical translation pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation company research pharmaceutical article contract pharmaceutical pharmaceutical consulting pharmaceutical industry biotech industry

Bookmark With:

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.